Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Orthopaedics and Trauma
Orthopaedics and Trauma publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 12 (Search time: 0.002 seconds).
previous
1
2
next
Item hits:
Preview
Issue Date
Title
Author(s)
2006
The histone deacetylase inhibitor, suberoylanilide hydroxamic acid, overcomes resistance of human breast cancer cells to Apo2L/TRAIL
Butler, L.
;
Liapis, V.
;
Bouralexis, S.
;
Welldon, K.
;
Hay, S.
;
Thai, L.
;
Labrinidis, A.
;
Tilley, W.
;
Findlay, D.
;
Evdokiou, A.
2004
Sensitivity of fresh isolates of soft tissue sarcoma, osteosarcoma and giant cell tumour cells to Apo2L/TRAIL and doxorubicin
Bouralexis, S.
;
Clayer, M.
;
Atkins, G.
;
Labrinidis, A.
;
Hay, S.
;
Graves, S.
;
Findlay, D.
;
Evdokiou, A.
2002
Zoledronate is anabolic for human osteoblast-like cells
Atkins, G.
;
Pan, B.
;
Findlay, D.
;
To, L.
;
Evdokiou, A.
;
Labrinidis, A.
;
Bouralexis, S.
;
Zannettino, A.
;
American Society for Bone and Mineral Research. Conference (24th : 2002 : San Antonio, Texas)
2003
Progressive resistance of BTK-143 osteosarcoma cells to Apo2L/TRAIL-induced apoptosis is mediated by acquisition of DcR2/TRAIL-R4 expression: resensitisation with chemotherapy
Bouralexis, S.
;
Findlay, D.
;
Atkins, G.
;
Labrinidis, A.
;
Hay, S.
;
Evdokiou, A.
2011
Anticancer efficacy of Apo2L/TRAIL is retained in the presence of high and biologically active concentrations of osteoprotegerin in vivo
Zinonos, I.
;
Labrinidis, A.
;
Lee, M.
;
Liapis, V.
;
Hay, S.
;
Ponomarev, V.
;
Diamond, P.
;
Findlay, D.
;
Zannettino, A.
;
Evdokiou, A.
2010
Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model
Labrinidis, A.
;
Hay, S.
;
Liapis, V.
;
Findlay, D.
;
Evdokiou, A.
2002
Human osteoblasts are resistant to Apo2L/TRAIL-mediated apoptosis
Atkins, G.
;
Bouralexis, S.
;
Evdokiou, A.
;
Hay, S.
;
Labrinidis, A.
;
Zannettino, A.
;
Haynes, D.
;
Findlay, D.
2003
Induction of cell death of human osteogenic sarcoma cells by zoledronic acid resembles anoikis
Evdokiou, A.
;
Labrinidis, A.
;
Bouralexis, S.
;
Hay, S.
;
Findlay, D.
2008
Does Apo2LTRAIL play any physiologic role in osteoclastogenesis?
Labrinidis, A.
;
Liapis, V.
;
Thai, L.
;
Atkins, G.
;
Vincent, C.
;
Hay, S.
;
Sims, N.
;
Zannettino, A.
;
Findlay, D.
;
Evdokiou, A.
2009
Apomab, a fully human agonistic antibody to DR5, exhibits potent antitumor activity against primary and metastatic breast cancer
Zinonos, I.
;
Labrinidis, A.
;
Lee, M.
;
Liapis, V.
;
Hay, S.
;
Ponomarev, V.
;
Diamond, P.
;
Zannettino, A.
;
Findlay, D.
;
Evdokiou, A.
Discover
Author
11
Hay, S.
7
Liapis, V.
6
Atkins, G.
6
Bouralexis, S.
6
Zannettino, A.
4
Ponomarev, V.
3
Diamond, P.
3
Zinonos, I.
2
Lee, M.
2
Sims, N.
.
next >
Subject
5
Apoptosis
5
Humans
4
Animals
4
Apo2L/TRAIL
4
Female
4
Osteolysis
3
Cell Line, Tumor
3
Mice
3
Osteosarcoma
3
TNF-Related Apoptosis-Inducing Li...
.
next >
Date issued
1
2011
1
2010
3
2009
1
2008
1
2006
1
2004
2
2003
2
2002